CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- 4 Planned sale Chief Medical Officer sold 10,000 shares at $40.09 ($400,900)
- 4 Planned sale President and CEO sold 28,125 shares at an average $41.89 ($1,178,156)
- 4 Planned sale Director sold 7,000 shares at $39.98 ($279,860)
- 4 Option exercise Director acquired 3,200 shares (option exercise)
- 4 Option exercise Director acquired 3,200 shares (option exercise)
- 4 Option exercise Director acquired 3,200 shares (option exercise)
- 4 Option exercise Director acquired 3,200 shares (option exercise)
- 4 Option exercise Director acquired 3,200 shares (option exercise)
- 4 Option exercise Director acquired 3,200 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Planned sale President and CEO sold 49,700 shares at an average $41.50 ($2,062,550)
- 4 Planned sale President and CEO sold 53,183 shares at an average $46.04 ($2,448,811)
- 4 Planned sale Chief Operating Officer sold 10,000 shares at $49.52 ($495,200)
- 4 Planned sale Director sold 9,000 shares at $49.53 ($445,770)
- 4 Planned sale Chief Financial Officer sold 9,000 shares at $49.53 ($445,770)
- 4 Planned sale Chief Medical Officer sold 10,000 shares at $49.53 ($495,300)
- 4 Shares withheld for taxes Chief Medical Officer gave up 636 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 8,459 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 2,486 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,358 shares (to pay taxes)
Page 4 of 32 · 637 filings